Marvell Technology Shares Plummet Amid AI Market Turmoil
January 28, 2025 - 01:43
Shares of networking chip designer Marvell Technology experienced a dramatic decline of 16.6% during the morning trading session. This sharp drop is attributed to a broader downturn in stocks closely associated with the artificial intelligence sector. The catalyst for this market shift was the announcement from Chinese AI startup DeepSeek, which unveiled its new large language model, DeepSeek-R1.
This model has demonstrated competitive performance on key global benchmarks, including coding competitions and mathematical evaluations. Notably, DeepSeek-R1 utilizes less advanced semiconductor chips, which significantly reduces production costs, bringing the total to just $5.5 million, excluding non-compute expenses.
The introduction of such an efficient and cost-effective AI model has raised concerns among investors regarding the competitive landscape in the AI chip market. As companies like Marvell Technology grapple with these emerging technologies, the volatility in their stock prices reflects the uncertainty and challenges they face in adapting to rapid advancements in AI capabilities.
MORE NEWS
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...